• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Off-the-shelf tool for making mouse models of COVID-19

Bioengineer by Bioengineer
June 16, 2020
in Biology
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

University of Iowa team makes gene therapy approach freely available for COVID-19 research

IMAGE

Credit: University of Iowa Health Care

Until there are effective treatments or vaccines, the COVID-19 pandemic will remain a significant threat to public health and economies around the world. A major hurdle to developing and testing new anti-viral therapies and vaccines for COVID-19 is the lack of good, widely available animal models of the disease.

Researchers at the University of Iowa Carver College of Medicine and Medical University, Guangzhou, in China, have developed a simple tool to overcome that bottleneck. The researchers have created a gene therapy approach that can convert any lab mouse into one that can be infected with SARS-CoV-2 and develops COVID-like lung disease. The international team, led by Paul McCray, MD, and Stanley Perlman, PhD, at the UI, and Jincun Zhao, PhD, at Medical University, Guangzhou, have made their gene therapy vector freely available to any researchers who want to use it.

“There is a pressing need to understand this disease and to develop preventions and treatments,” says McCray, UI professor of pediatrics, and microbiology and immunology. “We wanted to make it as easy as possible for other researchers to have access to this technology, which allows any lab to be able to immediately start working in this area by using this trick.”

The “trick” is the use of an adenovirus gene therapy vector that is inhaled by the mice to deliver the human ACE2 protein into mouse airway cells. This is the protein that SARS-CoV-2 uses to infect cells. Once the mouse airway cells express the hACE2 protein, the mice become susceptible to infection with SARS-CoV-2 and they develop COVID-19-like lung symptoms. Although the disease is not fatal in the mice, the animals do get sick, losing weight and developing lung damage. Importantly, the vector is readily adaptable to any strain of mice (and other lab animals), which means research teams can rapidly convert mice with specific genetic traits into animals that are susceptible to SARS-Cov-2, allowing them to test whether those traits influence the disease.

Reporting in Cell, the researchers showed that mice treated with this gene therapy could be used to evaluate a vaccine and several potential COVID-19 therapies, including a preventative strategy known as poly I:C, which boosts the innate immune response, convalescent plasma from recovered COVID-19 patients, and the anti-viral drug remdesivir. In each case, the therapies prevented weight loss, reduced lung disease, and increased the speed of virus clearance in the mice. The team also showed mice are useful for studying important immune responses involved in clearing the SARS-CoV-2 virus.

Mice are the most commonly used experimental animal for studying human disease in the lab because they are accessible, inexpensive, and easy to use. They are also one of the easier animal models to use in biosafety level three environments, which are needed for work on COVID-19. However, due to differences between the human and mouse ACE2 protein, wild-type mice are not susceptible to the SARS-Cov-2 virus.

The gene therapy vector is essentially an off-the-shelf tool that allows labs to create their own COVID-19 mouse model within a few days. McCray, Zhao, and Perlman developed this approach in 2014, when Zhao was a postdoctoral researcher in Perlman’s UI lab, to create mouse models of MERS.

“You can create these mice very quickly. You don’t have to breed the strain, which is very time consuming and expensive,” McCray explains. “We think this technology will be useful for investigating COVID-19 lung disease and rapidly testing interventions that people think are promising for treating or preventing COVID-19.”

###

McCray credits the UI’s long-standing expertise in gene therapy vector development as a basis for this advance. The vector was made in the University of Iowa Vector Core, which is an outgrowth of the UI Center for Gene Therapy for Cystic Fibrosis funded by the National Institutes of Health. The vector is freely available through the BEI Resources Repository at the National Institute of Allergy and Infectious Diseases (NIAID).

The research was supported by the grants from the NIH (AI060699 and AI129269 and DK-54759), and the Cystic Fibrosis Foundation. Zhao and his team also received funding from several Chinese governmental organizations. McCray also is supported by the Roy J. Carver Charitable Trust.

Media Contact
Jennifer Brown
jennifer-l-brown@uiowa.edu

Related Journal Article

http://dx.doi.org/10.1016/j.cell.2020.06.010

Tags: Gene TherapyInfectious/Emerging DiseasesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Engineered E. coli Secretes Thermophilic Cellulase Cocktail for Seawater-Compatible Biorefining

Engineered E. coli Secretes Thermophilic Cellulase Cocktail for Seawater-Compatible Biorefining

November 17, 2026
Pregnancy Significantly Alters Pharmacokinetics of Anti-Inflammatory Drug Flunixin in Goats

Pregnancy Significantly Alters Pharmacokinetics of Anti-Inflammatory Drug Flunixin in Goats

November 17, 2026

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

November 17, 2026

Engineered Escherichia Coli Produces C14-Enriched Lipid Adjuvant Homologs in Bioreactor Batches

November 17, 2026
Please login to join discussion

POPULAR NEWS

  • Digital Twin Framework Preserves Cultural Embroidery Patterns While Reducing Stitch Positioning Errors

    Digital Twin Framework Preserves Cultural Embroidery Patterns While Reducing Stitch Positioning Errors

    29 shares
    Share 12 Tweet 7
  • Post-Jail Intervention Increases Housing Contacts but Does Not Lower Rearrest Rates

    29 shares
    Share 12 Tweet 7
  • Porous Transport Layer Architecture Governs Performance in Anion Exchange Water Electrolysis

    29 shares
    Share 12 Tweet 7
  • FinGPT-Risk Framework Enhances Multi-Task Financial Risk Prediction Across Seven Benchmark Datasets

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.